BRIEF published on 09/26/2025 at 14:50, 4 months 21 days ago EnVVeno Medical Engages in Virtual Investor Segment Amid FDA Appeal Medical Devices EnVVeno Medical VenoValve Chronic Venous Insufficiency FDA Appeal
PRESS RELEASE published on 09/26/2025 at 14:45, 4 months 21 days ago enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment enVVeno Medical Corporation announces CEO Robert Berman's participation in a Virtual Investor segment discussing the supervisory appeal for VenoValve® with FDA FDA EnVVeno Medical VenoValve Virtual Investor Supervisory Appeal
BRIEF published on 09/15/2025 at 14:50, 5 months 2 days ago EnVVeno Medical dépose un recours auprès de la FDA EnVVeno Medical Insuffisance Veineuse Chronique Valve VenoValve Appel Auprès De La FDA Processus Réglementaire
BRIEF published on 09/15/2025 at 14:50, 5 months 2 days ago EnVVeno Medical Pursues FDA Supervisory Appeal EnVVeno Medical VenoValve Chronic Venous Insufficiency Regulatory Process FDA Appeal
PRESS RELEASE published on 09/15/2025 at 14:45, 5 months 2 days ago enVVeno Medical Updates Regulatory Status of VenoValve(R) enVVeno Medical Corporation to file supervisory appeal with FDA regarding not-approvable letter for VenoValve® submission to treat deep venous CVI, aiming to bring innovative solution to patients FDA EnVVeno Medical Corporation VenoValve® Deep Venous Disease Supervisory Appeal
BRIEF published on 08/20/2025 at 13:05, 5 months 28 days ago EnVVeno Medical Receives Not-Approvable Letter from FDA for VenoValve EnVVeno Medical VenoValve FDA Decision Deep Venous Disease Premarket Approval
BRIEF published on 08/20/2025 at 13:05, 5 months 28 days ago EnVVeno Medical reçoit une lettre de non-approbation de la FDA pour VenoValve EnVVeno Medical Valve VenoValve Décision De La FDA Maladie Veineuse Profonde Approbation Préalable À La Mise Sur Le Marché
PRESS RELEASE published on 08/20/2025 at 13:00, 5 months 28 days ago enVVeno Receives Not-Approvable Letter from the FDA for the VenoValve(R) enVVeno Medical received a not-approvable letter from the FDA for VenoValve, citing lacking hemodynamic data and safety concerns. Company to work on new criteria and potential resubmission FDA Medical Device EnVVeno Medical VenoValve CVI
BRIEF published on 08/15/2025 at 15:26, 6 months 2 days ago EnVVeno Medical participera à la série de webinaires financiers Webull EnVVeno Medical Valve VenoValve Maladie Veineuse Profonde Webull Financial Biotechnologie/Technologie Médicale
BRIEF published on 08/15/2025 at 15:26, 6 months 2 days ago EnVVeno Medical to Present at Webull Financial Webinar Series EnVVeno Medical VenoValve Deep Venous Disease Webull Financial Biotech/MedTech
Published on 02/18/2026 at 11:00, 36 minutes ago The Numbers are Clear: Latest Iteration of Stagwell's News Advertising Study Shows Germans Love Their News
Published on 02/18/2026 at 09:05, 2 hours 31 minutes ago Nano One fournit une mise à jour corporative
Published on 02/18/2026 at 01:00, 10 hours 36 minutes ago urban-gro, Inc. Completes Merger with Flash Sports and Media Inc., Providing Shareholders with Access to the Rapidly Evolving Sports & Media Digital Landscape
Published on 02/18/2026 at 11:19, 17 minutes ago Introducing Dash: HomeToGo’s AI travel companion that optimizes accuracy and Customer Experience efficiency, cutting escalations by 85%
Published on 02/18/2026 at 10:00, 1 hour 36 minutes ago Invitation to the International Investment Forum (IIF) / ONLINE on February 25, 2026
Published on 02/18/2026 at 09:12, 2 hours 23 minutes ago Encavis secures major allocation in Italy’s Energy Release 2.0 programme
Published on 02/18/2026 at 09:10, 2 hours 25 minutes ago Rudholm Group Launches Compliance Portal to Simplify Global Regulatory Complexity for Apparel Brands
Published on 02/18/2026 at 11:00, 35 minutes ago Mise à disposition des documents préparatoires à l'AG
Published on 02/18/2026 at 08:07, 3 hours 29 minutes ago TERACT - Modification du calendrier financier
